Status:
COMPLETED
A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Skin Androgenization
Eligibility:
FEMALE
50-65 years
Phase:
PHASE1
Brief Summary
Postmenopausal women will receive testosterone gel or matching placebo gel daily. Sebum excretion rates will be measured before and after 6 weeks of treatment.
Eligibility Criteria
Inclusion
- Subject is at least 3 years postmenopausal
- Subject is in good general health
- Subject is willing to avoid excess alcohol or strenuous physical activity during the study
Exclusion
- Subject has donated a unit of blood or has taken an investigational drug in another clinical trial in the last 4 weeks
- Subject is a regular user of any illicit drugs
- Subject drinks excessive amounts of coffee, tea or cola
- Subject has used an estrogen or progestogens hormone replacement therapy in the past 6 months
- Subject has a history of cancer
- Subject has acne
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00969163
Start Date
October 1 2004
End Date
June 1 2005
Last Update
September 4 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.